| Improved solubility of IRAK-4 CODA was able to increase total solubility by 38.4%. A deletion library was constructed by multiplexing PCR against the IRAK-4 Hot Rod template with 5 and 3’ over-lapping primers for sequential N- and C-terminus truncations. The deletion library was then screened by a proprietary selection filter. Potential soluble clones were identified, sequenced and verified for soluble expression.
|
Figure: Improved solubility for IRAK4 deletion variants. Proteins were expressed from a pET vector in E. coli strain BL21(DE3), inducing with 1 mM IPTG for 3 hours at 30°C. Lane M: molecular weight markers (in kDa). Lanes 1-4, full-length IRAK4: uninduced total protein, induced total protein, induced insoluble fraction, and induced soluble fraction, respectively. Lanes 5-8, IRAK4 deletion clone #21: uninduced total protien, induced total protein, induced insoluble fraction, and induced soluble fraction, respectively. Lanes 9-12, IRAK4 deletion clone #12: uninduced total protein, induced total protein, induced insoluble fraction, and induced soluble fraction, respectively. Left panel, Coomassie Blue staining; Right panel, western blot analysis using Anti-6xHis antibody.
|
|||||||||||||||||||||||||||||||||||
Improved solubility of (TEL)-SAM clones using Combinatorial Library (CL) approach |
||||||||||||||||||||||||
Figure: Improved solubility for CL (TEL)-SAM clone TSM#40 discretely expressed as pET constructs in E. coli. Lane M: molecular size markers (in kDa); Lanes 1-4: Un-induced (TEL)-SAM Hot Rod clone, induced with 1 mM IPTG, induced insoluble fraction, and induced soluble fraction at 30°C for 3 hrs; Lanes 5-8: Un-induced CL clone TSM#40, induced with 1 mM IPTG, induced insoluble fraction, and induced soluble fraction at 30°C for 3 hrs.
|
|
|||||||||||||||||||||||
| Improved solubility of a Interleukin-2 clone using
a Combinatorial Library (CL) approach
CODA was able to increase solubility by 13%. |
|||||||||||||||||||||||||||
|
Figure: Improved solubility for IL-2 (134 amino acids without the signal peptide) mutant clones discretely expressed as pET constructs in E. coli. Lane M: molecular size markers (in kDa); Lanes 1-4: Un-induced IL-2 Hot Rod clone, induced with 1 mM IPTG, induced insoluble fraction, and induced soluble fraction at 30°C for 3 hrs; Lanes 5-8: Un-induced CL mutant clone #9, induced with 1 mM IPTG, induced insoluble fraction, and induced soluble fraction at 30°C for 3 hrs; Lanes 9-12: Un-induced SolSelect CL mutant clone #42, induced with 1 mM IPTG, induced insoluble fraction, and induced soluble fraction at 30°C for 3 hrs. |
||||||||||||||||||||||||||
Client Therapeutic Protein Expression Yield Increased by 65X. |
|
|||
| A collaborator in CODA's Academic Access program designed three entirely synthetic proteins consisting of peptides concatenated from multiple protein targets. As a result of CODA's Translation Engineering, all three proteins were expressed at high levels without further optimization. |
![]() |
|||